Global Clinical Trial Supplies Market Report 2022: Industry to Grow by 10.84% CAGR Through 2029 - ResearchAndMarkets.com
The "Clinical Trial Supplies Market Analysis by Services, by Phase, by Type, by Therapeutic Area, by End use by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The clinical trial supplies market size is estimated to be USD 2.6 billion in 2021 and is expected to witness a CAGR of 10.84% during the forecast period 2022-2029. The rising R&D spending in pharmaceutical and biopharmaceutical firms, and the expanding number of clinical trials done internationally are the factors driving the market growth. However, rising cost of medication development and clinical trials is expected to limit the market growth.
This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including anatomy, drug type, route of administration, purchasing pattern, and distribution channel from 2021 to 2029.
Segmentation: Osteoarthritis Therapeutics Market Report 2021-2029 By Anatomy (Revenue, USD Billion)
- Hip Osteoarthritis
- Knee Osteoarthritis
- Small Joint Osteoarthritis
- Hand Osteoarthritis
By Drug Type (Revenue, USD Billion)
- Analgesics
- Corticosteroids
- Viscosupplementation Agents
- Nonsteroidal Anti-inflammatory Drugs
By Route of Administration (Revenue, USD Billion)
- Topical Route
- Oral Route
- Parenteral Route
By Purchasing Pattern (Revenue, USD Billion)
- Prescription Drugs
- Over-the-Counter Drugs
By Distribution Channel (Revenue, USD Billion)
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
By Region (Revenue, USD Billion)North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Clinical Trial Supplies
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Clinical Trial Supplies Market
7. Market Analysis by Services
8. Market Analysis by Phase
9. Market Analysis by Type
10. Market Analysis by Therapeutic Area
11. Market Analysis by End user
12. Regional Market Analysis
13. North America Clinical Trial Supplies Market
14. Europe Clinical Trial Supplies Market
15. Asia Pacific Clinical Trial Supplies Market
16. Latin America Clinical Trial Supplies Market
17. MEA Clinical Trial Supplies Market
18. Competitor Analysis
19. Company Profiles
20. Conclusion & Recommendations
Companies Mentioned
- Thermo Fisher (US)
- Catalent Inc. (US)
- Parexel (US)
- Eurofins (France) UDG Healthcare (Ireland)
- Piramal Pharma Solutions (India)
- Almac Group (UK)
- PCI Pharma Services (US)
- PRA Health Sciences (US)
- Biocair (UK)
- Eurofins (France)
- Marken (US)
- Infosys (India)
- Liveo Research (India)
- Capsugel (a Lonza Group company) (Switzerland)
- SIRO Clinpharm (India)
- KLIFO A/S (Denmark)
- Clinigen (UK)
- Ancillare (US)
- N-SIDE (Belgium)
- ADAllen (UK)
- Rubicon (India)
- Durbin (UK)
- Recipharm (Sweden)
- Seveillar (India)
- Myonex (India).
For more information about this report visit https://www.researchandmarkets.com/r/noi370
These press releases may also interest you
|
News published on and distributed by:
